Amgen (AMGN) EBITDA Margin (2009 - 2026)
Amgen's EBITDA Margin was 46.01% in Q2 2026, up 2.47 percentage points from 43.55% a year earlier and up 2.13 percentage points from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amgen's EBITDA Margin was 42.24% through Jun 30, 2026, up 2.97 percentage points year-over-year; for FY2025, it was 38.77%, up 0.32 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -11.34 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 38.45% in FY2024 (-4.01 pp), 42.45% in FY2023 (-6.87 pp), 49.32% in FY2022 (+6.84 pp) and 42.48% in FY2021 (-7.63 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2023.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +2.86 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2022 (a gain of 19.77 percentage points); the worst was Q1 2024 (a drop of 14.11 percentage points).
- Per Business Quant data, AMGN's EBITDA Margin in the three quarters before Q2 2026 was 43.88% (Q1 2026), 39.04% (Q4 2025) and 40.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 22.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 46.62% |
| Jun 30, 2026 | 46.01% |
| Mar 31, 2026 | 43.88% |
| Dec 31, 2025 | 39.04% |
| Sep 30, 2025 | 40.11% |
| Jun 30, 2025 | 43.55% |
| Mar 31, 2025 | 31.48% |
| Dec 31, 2024 | 40.81% |
| Sep 30, 2024 | 40.49% |
| Jun 30, 2024 | 39.45% |
| Mar 31, 2024 | 32.09% |
| Dec 31, 2023 | 32.35% |
| Sep 30, 2023 | 42.24% |
| Jun 30, 2023 | 51.25% |
| Mar 31, 2023 | 46.21% |
| Dec 31, 2022 | 45.93% |
| Sep 30, 2022 | 52.57% |
| Jun 30, 2022 | 45.56% |
| Mar 31, 2022 | 53.56% |
| Dec 31, 2021 | 46.10% |
API Access
Amgen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();